Clinical trial
Randomized, Open-Label, 2-Way Crossover, 3-Period Study to Evaluate Single Doses of Diazepam Buccal Film Compared With Diazepam Rectal Gel in Adult Males and Females on Concomitant Antiepileptic Drugs for the Treatment of Epilepsy
NCT03953820 is registered in ClinicalTrials.gov with Aquestive Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Open-Label, 2-Way Crossover, 3-Period Study to Evaluate Single Doses of Diazepam Buccal Film Compared With Diazepam Rectal Gel in Adult Males and Females on Concomitant Antiepileptic Drugs for the Treatment of Epilepsy
- Lead sponsor
- Aquestive Therapeutics
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 13, 2019
- Completion date
- July 31, 2019
- Enrollment
- 31 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.